Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.620
-0.030 (-1.13%)
Jan 22, 2025, 10:53 AM EST - Market open
Sonoma Pharmaceuticals Employees
Sonoma Pharmaceuticals had 10 employees as of March 31, 2024. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
$1,354,700
Profits / Employee
-$368,600
Market Cap
3.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
SNOA News
- 6 weeks ago - Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices - Accesswire
- 2 months ago - Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States - Accesswire
- 2 months ago - Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel - Accesswire
- 2 months ago - Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results - Accesswire
- 2 months ago - Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf - Accesswire
- 3 months ago - Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada - Accesswire
- 3 months ago - Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences - Accesswire
- 4 months ago - Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule - Accesswire